Adaltis Inc.
TSX : ADS

Adaltis Inc.

August 12, 2008 12:00 ET

Notice of Adaltis 2008 Second Quarter Financial Results Conference Call

MONTREAL, QUEBEC--(Marketwire - Aug. 12, 2008) - Adaltis Inc. (TSX:ADS), an international in vitro diagnostic company, will release its 2008 second quarter results on Thursday, August 14, 2008, prior to market opening. A conference call for investors is scheduled to be held on the same day at 9:00 a.m. (ET). Mr. Pierre Larochelle, President and Chief Executive Officer, Mr. Jacques Deforges, Vice President, Finance and Chief Financial Officer, and Dr. Raymond Tong, Chief Operating Officer, will participate in the conference call.

Conference call details:



Date: Thursday, August 14, 2008

Time: 9:00 a.m. (ET)

Dial-in number: 1-888-300-0053 (Canada/US) or
1-647-427-3420 (International)

Conference code: 59682762

Live audio Webcast: Adaltis' Web site, "Investor Relations" section,
at www.adaltis.com


If you are unable to participate in the conference call, a replay will be available starting the same day by audio Webcast on Adaltis' Web site for 30 days.

About Adaltis

Adaltis is an international in vitro diagnostic company that develops, manufactures and markets diagnostic systems. It aims to leverage its experience in Europe to become a leading provider of in vitro diagnostic products in emerging markets, with a particular focus on China.

With the assistance of its two strategic shareholders, CITIC Pacific Limited (a large Hong Kong-based conglomerate) and Picchio Pharma Inc. (a joint venture healthcare investment firm owned by FMRC Family Trust (a trust of which Dr. Francesco Bellini is a beneficiary), and Power Technology Investment Corporation, a subsidiary of Power Corporation of Canada), Adaltis has completed building its manufacturing facility in Shanghai. Now operational, the production facility manufactures high-quality products in a low-cost GMP environment, in order to service existing markets in Europe, while providing a platform to penetrate the high-growth Chinese in vitro diagnostic market.

Adaltis is headquartered in Montreal, with offices in China, Hong Kong, Italy and Mexico.

Contact Information